Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$24K Sell
300
-250,900
-100% -$18.9M ﹤0.01% 7750
2014
Q2
$17.8M Buy
251,200
+250,700
+50,140% +$17.6M 0.01% 951
2014
Q1
$37K Sell
500
-6,300
-93% -$475K ﹤0.01% 7239
2013
Q4
$534K Buy
6,800
+900
+15% +$70.5K ﹤0.01% 4250
2013
Q3
$436K Sell
5,900
-16,300
-73% -$1.2M ﹤0.01% 4287
2013
Q2
$1.69M Buy
+22,200
New +$1.46M ﹤0.01% 2732

Other funds holding CME

UBS's CME Position: Q3 2014 in Review

UBS increased its CME Group (CME) stake by 19% in Q3 2014, buying an estimated $14.4M and bringing the position to 1,219,548 shares worth $97.5M. The position accounts for 0.07% of the portfolio, ranked #272.

UBS first reported a position in CME in Q2 2013 and has held it in 6 quarters since. 543 funds tracked by Wall St. Rank hold CME as of Q3 2014.

  • UBS held 1,219,548 shares of CME Group worth $97.5M as of Q3 2014.
  • UBS bought 191,537 CME Group shares in Q3 2014, an estimated $14.4M.
  • CME Group made up 0.07% of UBS's portfolio in Q3 2014, its #272 holding.
  • UBS first reported a position in CME Group in Q2 2013 and has held it in 6 quarters since.
  • 543 funds tracked by Wall St. Rank held CME Group as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.